{
    "2019-09-04": [
        [
            {
                "time": "",
                "orginal_text": "医药生物行业2019H1业绩总结：行业增速放缓，龙头引领增长，聚焦创新药产业链、创新生物制品、医疗服务等景气细分赛道",
                "features": {
                    "keywords": [
                        "医药生物",
                        "行业增速",
                        "龙头",
                        "创新药",
                        "生物制品",
                        "医疗服务"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "郭广昌失策二十年，复星医药市值落后50倍，医药龙头孙飘扬笑了",
                "features": {
                    "keywords": [
                        "郭广昌",
                        "复星医药",
                        "市值",
                        "孙飘扬"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "",
                "orginal_text": "复星医药:19H1收入增长稳健,费用增加拖累利润 盈利能力下降",
                "features": {
                    "keywords": [
                        "复星医药",
                        "收入增长",
                        "费用增加",
                        "盈利能力"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}